Sponsor or institution
Clinical trials and research at Sigmovir Biosystems, INC.
As of November 12, 2026, Find a Trial lists 7 NIH-funded research projects at this institution, with $1.6 million in listed awards. Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 7NIH research projects
NIH-funded research (7)
Early-stage science funded by the US National Institutes of Health. Most of these projects don't enroll patients, but they show what is being worked on.
-
Evaluating vaccines and treatments for respiratory viruses using cotton rats.
This study is looking at how well new vaccines and treatments for respiratory syncytial virus (RSV) work by testing them on cotton rats first, so we can make sure they're safe and effective for people later on.
-
Developing models to understand infectious diseases.
This study is working on building models that mimic infectious diseases to help us learn more about how they work and find better treatments, which could ultimately help patients like you get improved care and prevention options.
-
Developing antibodies to study immune cells in cotton rats.
This study is all about developing special tools to help scientists see and understand how different immune cells work in cotton rats, which can be really helpful for learning more about diseases.
-
Targeting a protein to reduce lung injury caused by viral infections.
This study is looking at a new way to help people with lung injuries and breathing problems caused by viral infections, like COVID-19, by blocking a protein that makes inflammation worse, with the hope of improving their lung function.
-
Drugs that activate RXR and PPARγ to reduce virus-related lung injury
This project tests whether activating two cellular receptors (RXR and PPARγ) can push immune cells toward healing and reduce lung damage after viral infections like flu or RSV.
-
Investigating new treatments for lung injury caused by viruses
This study is looking at how special immune cells in your lungs respond to viral infections that can cause serious breathing problems, and it aims to find new ways to help heal your lungs if you have conditions like ARDS.
-
Targeting a protein to reduce lung injury caused by viral infections.
This study is looking at a new treatment to help people with serious lung problems caused by viral infections, like COVID-19, by blocking a specific protein that makes inflammation worse, and it's being tested in models that act like human conditions.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.